Literature DB >> 18327778

Transoral laser surgery for supraglottic cancer.

Juan P Rodrigo1, Carlos Suárez, Carl E Silver, Alessandra Rinaldo, Petra Ambrosch, Johannes J Fagan, Eric M Genden, Alfio Ferlito.   

Abstract

The goal of treatment for supraglottic cancer is to achieve cure and to preserve laryngeal function. Organ preservation strategies include both endoscopic and open surgical approaches as well as radiation and chemotherapy. The challenge is to select the correct modalities for each patient. Endoscopic procedures should be limited to tumors that can be completely visualized during diagnostic microlaryngoscopy. If complete resection can be achieved, the oncologic results of transoral laser surgery appear to be comparable to those of classic supraglottic laryngectomy. In addition, functional results of transoral laser resection are superior to those of the conventional open approach, in terms of the time required to restore swallowing, tracheotomy rate, incidence of pharyngocutaneous fistulae, and shorter hospital stay. The management of the neck remains of paramount importance, as survival of patients with supraglottic cancer depends more on cervical metastasis than on the primary tumor. Most authors advocate bilateral elective neck dissection. However, in selected cases (T1,T2 clinically negative [N0] lateral supraglottic cancers), ipsilateral selective neck dissection could be performed without compromising survival. The authors conclude that with careful selection of patients, laser supraglottic laryngectomy is a suitable, and often the preferred, treatment option for supraglottic cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18327778     DOI: 10.1002/hed.20811

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  16 in total

1.  Autofluorescence guided welding of heart tissue by laser pulse bursts at 1550 nm.

Authors:  Karina Litvinova; Maria Chernysheva; Berthold Stegemann; Francisco Leyva
Journal:  Biomed Opt Express       Date:  2020-10-09       Impact factor: 3.732

Review 2.  Transoral microsurgery for treatment of laryngeal and pharyngeal cancers.

Authors:  Carlos Suárez; Juan P Rodrigo
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

3.  Transoral resection of laryngeal and hypopharyngeal cancers.

Authors:  Sultan Pradhan; Marzi Mehta; Arsheed Hakeem; Jagadish Tubachi; R Kannan
Journal:  Indian J Surg Oncol       Date:  2010-11-21

4.  Transoral CO₂ laser surgery for supraglottic cancer.

Authors:  Rocío González-Márquez; Juan P Rodrigo; Jose Luis Llorente; Cesar Alvarez-Marcos; Juan P Díaz; Carlos Suárez
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-04-07       Impact factor: 2.503

Review 5.  Current trends in initial management of laryngeal cancer: the declining use of open surgery.

Authors:  Carl E Silver; Jonathan J Beitler; Ashok R Shaha; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-14       Impact factor: 2.503

6.  Occult metastases from T1-T2 supraglottic carcinoma: role of primary tumor localization.

Authors:  Imdat Yüce; Sedat Cağli; Ali Bayram; Ercihan Güney
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-11-05       Impact factor: 2.503

7.  Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma.

Authors:  Jian Chen; Sulin Zhang; Yuncheng Li; Zhengang Tang; Weijia Kong
Journal:  Tumour Biol       Date:  2013-12-21

8.  Ablation Precision and Thermal Effects of a Picosecond Infrared Laser (PIRL) on Roots of Human Teeth: A Pilot Study Ex Vivo.

Authors:  Reinhard E Friedrich; Maria Quade; Nate Jowett; Peter Kroetz; Michael Amling; Felix K Kohlrusch; Jozef Zustin; Martin Gosau; Hartmut SchlÜter; R J Dwayne Miller
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

9.  Transoral resection of supraglottic tumours using microelectrodes (54 cases).

Authors:  Jorge Basterra; Francisco Esteban; Rosa Reboll; Alicia Menoyo; Enrique Zapater
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-03       Impact factor: 2.503

10.  Transoral treatment strategies for head and neck tumors.

Authors:  Christoph Arens
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.